Literature DB >> 12579268

Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma.

Yasushi Toh1, Manabu Yamamoto, Kazuya Endo, Yasuharu Ikeda, Hideo Baba, Shunji Kohnoe, Hirotoshi Yonemasu, Yoichi Hachitanda, Takeshi Okamura, Keizo Sugimachi.   

Abstract

The alterations of the chromatin structure by histone acetylases (HATs) and histone deacetylases (HDACs) are implicated in the regulation of gene transcription and also in the process of carcinogenesis. HDAC inhibitors have been shown to be potent inducers of growth arrest, differentiation and/or apoptotic cell death of transformed cells and, as a result, they are currently receiving considerable attention as antitumor agents. In this study, we examined the status of histone H4 acetylation and the level of HDAC1 expression in surgically resected specimens of human esophageal squamous cell carcinoma by immunohistochemistry. We herein demonstrate that histone H4 of esophageal carcinoma cells was significantly hyperacetylated in the early stage of cancer invasion and thereafter changed into a hypoacetylated state according to the degree of cancer progression. The cases in which HDAC1 was less expressed in esophageal carcinoma cells than in the normal mucosa significantly increased as the carcinoma invaded into the deeper layers of the esophageal wall. Furthermore, both the hyperacetylation of histone H4 and the high expression of HDAC1 were shown to topologically colocalize in the same tumor. These results suggested that a dynamic equilibrium between the HAT and HDAC activities is disrupted in esophageal carcinoma, thus implying that a certain interaction may exist between the hyperacetylation of histone H4 and the HDAC1 expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12579268

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  22 in total

Review 1.  Causes of genome instability: the effect of low dose chemical exposures in modern society.

Authors:  Sabine A S Langie; Gudrun Koppen; Daniel Desaulniers; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Amaya Azqueta; William H Bisson; Dustin G Brown; Gunnar Brunborg; Amelia K Charles; Tao Chen; Annamaria Colacci; Firouz Darroudi; Stefano Forte; Laetitia Gonzalez; Roslida A Hamid; Lisbeth E Knudsen; Luc Leyns; Adela Lopez de Cerain Salsamendi; Lorenzo Memeo; Chiara Mondello; Carmel Mothersill; Ann-Karin Olsen; Sofia Pavanello; Jayadev Raju; Emilio Rojas; Rabindra Roy; Elizabeth P Ryan; Patricia Ostrosky-Wegman; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Frederik J Van Schooten; Mahara Valverde; Jordan Woodrick; Luoping Zhang; Nik van Larebeke; Micheline Kirsch-Volders; Andrew R Collins
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 2.  Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma.

Authors:  Yasushi Toh; Akinori Egashira; Manabu Yamamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-03-26

3.  Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.

Authors:  Theresa D Ahrens; Sylvia Timme; Jens Hoeppner; Jenny Ostendorp; Sina Hembach; Marie Follo; Ulrich T Hopt; Martin Werner; Hauke Busch; Melanie Boerries; Silke Lassmann
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

4.  Response of esophageal cancer cells to epigenetic inhibitors is mediated via altered thioredoxin activity.

Authors:  Theresa D Ahrens; Sylvia Timme; Jenny Ostendorp; Lioudmilla Bogatyreva; Jens Hoeppner; Ulrich T Hopt; Dieter Hauschke; Martin Werner; Silke Lassmann
Journal:  Lab Invest       Date:  2015-12-21       Impact factor: 5.662

Review 5.  Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis.

Authors:  Yasushi Toh; Eiji Oki; Kippei Ohgaki; Yasuo Sakamoto; Shuhei Ito; Akinori Egashira; Hiroshi Saeki; Yoshihiro Kakeji; Masaru Morita; Yoshihisa Sakaguchi; Takeshi Okamura; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2010-03-12       Impact factor: 3.402

6.  Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy.

Authors:  Scott Thomas; Kenneth T Thurn; Elona Biçaku; Douglas C Marchion; Pamela N Münster
Journal:  Breast Cancer Res Treat       Date:  2011-02-05       Impact factor: 4.872

7.  Enhanced radiosensitivity of EC109 cells by inhibition of HDAC1 expression.

Authors:  Bo Zhang; Yan Wang; Xueli Pang
Journal:  Med Oncol       Date:  2010-05-13       Impact factor: 3.064

8.  HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.

Authors:  Corrado Caslini; Sunhwa Hong; Yuguang J Ban; Xi S Chen; Tan A Ince
Journal:  Oncogene       Date:  2019-08-02       Impact factor: 9.867

9.  Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma.

Authors:  L Marquard; L M Gjerdrum; Ib J Christensen; P B Jensen; M Sehested; E Ralfkiaer
Journal:  Histopathology       Date:  2008-09       Impact factor: 5.087

10.  A unified 35-gene signature for both subtype classification and survival prediction in diffuse large B-cell lymphomas.

Authors:  Yu-Dong Cai; Tao Huang; Kai-Yan Feng; Lele Hu; Lu Xie
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.